Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
REGN
REGN News & Events
-
Add to Watchlist
Trade REGN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
REGN News
Analysis of Growth in Juvenile Idiopathic Arthritis Market
19h ago
Newsfilter
Ocular Therapeutix Shares Drop Following Axpaxli Trial Data Disappointment
1d ago
Benzinga
Atopic Dermatitis Market Growth Insights
1d ago
Newsfilter
Casgevy Therapy Revenue Shows Significant Growth
4d ago
Benzinga
Sanofi Faces Leadership Change Amid Drug Pipeline Challenges
5d ago
Benzinga
Regeneron Unveils 36 Allergy Treatment Abstracts at AAAAI 2026
Feb 10 2026
Newsfilter
Regeneron Reports Strong Q4 2024 Earnings with Key Growth Drivers
Feb 05 2026
Yahoo Finance
Regeneron Reports 11% Revenue Growth in Q3 2024 Earnings Call
Feb 05 2026
Yahoo Finance
Show More News
REGN Events
No data
REGN Monitor News
Regeneron reaches 52-week high amid market strength
Jan 07 2026
Regeneron shares rise on positive Lynozyfic trial results
Dec 10 2025
Dupixent Approved in EU for CSU Treatment
Nov 25 2025
Regeneron Reaches 20-Day High on Libtayo Approval
Nov 21 2025
Regeneron Hits 20-Day High on Libtayo Approval
Nov 20 2025
Regeneron Hits 20-Day High Amid Dividend News
Nov 18 2025
REGN Earnings Analysis
Regeneron Earnings Report: Strategic Growth in 2025- Intellectia AI™
19 days ago
Regeneron Earnings Soar in Q3 2025: Key Insights & Growth- Intellectia AI™
3 months ago
Regeneron Pharmaceuticals' Resilient Growth Amid Market Challenges - Intellectia AI™
1 years ago
Regeneron Pharmaceuticals Inc Q3 2024 Earnings Summary
1 years ago
People Also Watch
